Regulatory pressure is a key driver for substitution | Biocides Incentives needed for biocides innovation

Legislation on biocides was designed to create a demand for safer alternatives by removing the most toxic substances from use. Substances have been restricted, but is there enough innovation underway? We mapped the measures that are already in place to support innovation in biocides.

Legislation-built demand The most toxic active substances are not approved for use. This is to protect human and animal health, and the environment. A substance that, for example, has endocrine-disrupting properties or is classified as carcinogenic is not approved unless: i) it can be shown that the risk from exposure to it is negligible; ii) it is essential to prevent a serious danger to human or animal health or the environment; or iii) if not approving it would have a disproportionate negative impact on society.

“The paints industry selects substances for their best technical, efficacy, toxicological and cost profiles,” says Mr Didier Leroy, Technical Manager at the European Council of the Paint, Printing Ink and Artists' Colours Industry (CEPE). “Restricting any of the substances in legislation clearly leads to a need to substitute them with options that have a better ‘regulatory profile’. Nowadays, regulatory pressure is a key driver for substitution, but sometimes there are no suitable alternatives available.”



Related News